-
NCRTC adds high-speed CMV to Namo Bharat fleet
05 Dec 2025 23:56 GMT
… high-speed Catenary Maintenance Vehicle (CMV) to the Namo Bharat … the entire corridor. This CMV is indigenously manufactured in Uttarakhand … higher speed of this new CMV will, thus, ensure that … OHE-related issues, the CMV directly contributes to enhancing the …
-
ALEA partnering with ICE for coordinated CMV inspections
05 Dec 2025 21:46 GMT
… identified during Commercial Motor Vehicle (CMV) inspections. The majority of these … , approximately 242 individuals encountered during CMV inspections have been referred to …
-
Alabama detains 82 individuals in CMV inspections with ICE
04 Dec 2025 20:33 GMT
… were also integrated into routine CMV enforcement when available.
Since the …
-
Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025
06 Dec 2025 19:00 GMT
… with hypogammaglobulinemia. Perform screening for Cytomegalovirus (CMV), HBV, hepatitis C virus (HCV …
-
Earlier use of CARVYKTI® demonstrated lasting treatment-free remissions at 2.5 years in patients with relapsed or refractory multiple myeloma
06 Dec 2025 16:33 GMT
… with hypogammaglobulinemia. Perform screening for Cytomegalovirus (CMV), HBV, hepatitis C virus (HCV …
-
<![CDATA[Odronextamab Plus CHOP Shows Early Efficacy in DLBCL]]>
07 Dec 2025 03:57 GMT
… most commonly reported events were CMV infection or reinfection (27% for …
-
<![CDATA[Odronextamab Plus CHOP Shows Promise in Early Phase 3 Data for Untreated DLBCL]]>
07 Dec 2025 00:12 GMT
… most commonly reported events were CMV infection or reinfection (27% for …
-
Proteomic Identification of ALDOA as a Pathogenic TDP-43 Interaction Partner in ALS
06 Dec 2025 20:26 GMT
… pSLenti-EF1-EGFP-P2A-Puro-CMV-MCS-3×FLAG-WPRE), Flag … (pSLenti-EF1-EGFP-P2A-Puro-CMV-Tardbp(Tdp43)-3×FLAG-WPRE … (pSLenti-EF1-EGFP-P2A-Puro-CMV-Tardbp(p.M337V)-3×FLAG …
-
Outcomes often favorable after HCT for sickle cell disease
06 Dec 2025 17:38 GMT
… -2015 vs. 1996-2010);
Recipient cytomegalovirus-positive status: Reproductive organ dysfunction …
-
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
06 Dec 2025 16:52 GMT
… Grade 5 confusional state and cytomegalovirus infection reactivation in a 90 …